Fingerprint
Dive into the research topics of 'Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: Results from an open-label, multicenter phase i/ii study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically